Template File: /srv/users/serverpilot/apps/emquire/public/wp-content/themes/emquire2017/single-project.php | Template Hierarchy
WP version: 5.4.2
PHP version 7.1.33
Traditionally in the Emergency Department if a patient presents with exacerbation of COPD severe enough to require nebulisers they will be treated using a jet nebuliser which is driven through either air or Oxygen. Another type of nebuliser (Vibrating mesh nebuliser) is available, which silently creates a finer aerosol for delivery of drugs.
BRAVE (Borg score outcomes in Respiratory compromised Acute exacerbating COPD patients receiving treatment via vibrating mesh nebuliser Versus jet nebuliser in the Emergency department) is a trial which aims to compare outcomes in patients with acute exacerbation of COPD when treated using a traditional jet nebuliser versus a vibrating mesh nebuliser. It measures outcomes using a Borg score (Pt self assessment of how they are feeling) and Impulse Oscillometry (used to measure lung function). These outcomes can then be analysed to ascertain which delivery method yields the best outcomes for patients, thereby allowing for innovation and development of current practices.
The COVID-19 pandemic has led to unprecedented challenges to healthcare systems across the world. Enquire is contributing to NHS GGC response to this challenge across a range of projects. We have repurposed existing work streams including iCAIRD and TraumaApp with existing collaborators whilst building new relationships to develop solutions that can impact on care delivery. […]
Central Line setup and documentation https://emquire.care/project/central-line-qi-project/ Neuroprotection bundles coming soon
OCTS (Outcomes following Chest Trauma Score) has begun in the QEUH ED! This study aims to measure patient reported outcomes following rib fractures to optimise and improve care of this patient group. The patient will be asked to fill in a questionnaire at time of injury and two follow up questionnaires to assess how […]
Nicola was our first nurse appointed smashing the interview and rapidly getting a handle on the intricacies of clinical research in the ED. Her portfolio of studies includes She leads on Rapid-CTCA, Target-CTCA, SABER and Pro Teds
Mark was appointed in June 2017 and has rapidly found his feet helping promote QEUH ED nurse engagement. His infectious enthusiasm and energy will be a huge asset to the team! He leads on Novel, Aerogen, RAMPP, Frontiers
Introducing Dave the Trauma Man! The QEUH will become a Major Trauma Centre in 2019 as part of the Scottish Trauma Network. Dave is going to have a pretty tough year… in fact he is going to experience more car accidents, falls from height and industrial accidents than any other manikin in Scotland.